Published in J Vasc Interv Radiol on June 01, 2012
Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why? Radiographics (2014) 1.04
Mechanisms of cryoablation: clinical consequences on malignant tumors. Cryobiology (2013) 0.89
Cryotherapy with concurrent CpG oligonucleotide treatment controls local tumor recurrence and modulates HER2/neu immunity. Cancer Res (2014) 0.88
Soft-tissue cryoablation in diffuse locations: feasibility and intermediate term outcomes. J Vasc Interv Radiol (2013) 0.86
Bone and soft tissue ablation. Semin Intervent Radiol (2014) 0.80
Cryoablation of a small pulmonary nodule with pure ground-glass opacity: a case report. Korean J Radiol (2015) 0.78
Cost analysis of cryotherapy for metastatic disease. J Vasc Interv Radiol (2012) 0.75
CT-guided percutaneous cryoablation of central lung tumors. Diagn Interv Radiol (2014) 0.75
Cryoablation of cardiophrenic angle lymph node metastases: a case report. J Med Case Rep (2017) 0.75
Second-line treatment of advanced non-small cell lung cancer. J Thorac Oncol (2008) 3.95
Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol (1991) 3.01
Palliative thoracic radiotherapy for lung cancer: a systematic review. J Clin Oncol (2008) 2.50
Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg (1996) 2.21
Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology (2003) 1.85
Economic analysis: randomized placebo-controlled clinical trial of erlotinib in advanced non-small cell lung cancer. J Natl Cancer Inst (2010) 1.83
Revolution in lung cancer: new challenges for the surgical pathologist. Arch Pathol Lab Med (2011) 1.82
Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology (2005) 1.67
A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer. Lung Cancer (2003) 1.63
Surgical treatment of oligometastatic non-small cell lung cancer. Lung Cancer (2010) 1.47
CT-guided percutaneous cryotherapy of renal masses. J Vasc Interv Radiol (2007) 1.44
Thermal protection during percutaneous thermal ablation of renal cell carcinoma. J Vasc Interv Radiol (2004) 1.42
A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer. Ann Oncol (2011) 1.25
Successful treatment of solitary extracranial metastases from non-small cell lung cancer. Ann Thorac Surg (1995) 1.21
Lethal isotherms of cryoablation in a phantom study: effects of heat load, probe size, and number. J Vasc Interv Radiol (2009) 1.21
Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer. Cochrane Database Syst Rev (2010) 1.17
Cryotherapy for breast cancer: a feasibility study without excision. J Vasc Interv Radiol (2009) 1.13
Risk of high-grade bleeding in patients with cancer treated with bevacizumab: a meta-analysis of randomized controlled trials. Eur J Clin Pharmacol (2011) 1.12
Percutaneous cryoablation techniques and clinical applications. Diagn Interv Radiol (2009) 1.03
Treatment failure after percutaneous radiofrequency ablation for nonsurgical candidates with pulmonary metastases from colorectal carcinoma. Ann Surg Oncol (2007) 1.00
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer. Health Technol Assess (2001) 0.95
Imaging-guided percutaneous radiofrequency ablation of retroperitoneal metastatic disease in patients with gynecologic malignancies: clinical experience with eight patients. AJR Am J Roentgenol (2010) 0.91
Percutaneous radiofrequency thermal ablation in the management of lung tumors: presentation of clinical experience on a series of 35 patients. Diagn Interv Radiol (2009) 0.88
Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers. J Thorac Cardiovasc Surg (2004) 0.88
Cost-minimisation analysis comparing gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of advanced non-small cell lung cancer in Italy. Lung Cancer (2005) 0.83
Image-guided percutaneous cryotherapy for the management of gynecologic cancer metastases. Gynecol Oncol (2008) 0.82
Advanced non-small cell lung cancer: on relapse rechallenge the tumor, not the patient. BMC Res Notes (2010) 0.79
Evaluating Cryoablation of Metastatic Lung Tumors in Patients--Safety and Efficacy: The ECLIPSE Trial--Interim Analysis at 1 Year. J Thorac Oncol (2015) 2.75
Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies. J Clin Oncol (2005) 2.32
Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer. J Clin Oncol (2007) 2.16
Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology (2014) 1.78
Chronic obstructive lung diseases and risk of non-small cell lung cancer in women. J Thorac Oncol (2009) 1.74
Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology (2005) 1.67
An educational video to increase clinical trials enrollment among lung cancer patients. J Thorac Oncol (2008) 1.58
Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer. J Clin Oncol (2013) 1.55
Hospitalizations for critically ill children with traumatic brain injuries: a longitudinal analysis. Crit Care Med (2005) 1.55
Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancer. Clin Cancer Res (2011) 1.48
CT-guided percutaneous cryotherapy of renal masses. J Vasc Interv Radiol (2007) 1.44
Thermal protection during percutaneous thermal ablation of renal cell carcinoma. J Vasc Interv Radiol (2004) 1.42
Phase I and pharmacokinetic study of lapatinib and docetaxel in patients with advanced cancer. J Clin Oncol (2008) 1.37
A simplified analysis of [18F]3'-deoxy-3'-fluorothymidine metabolism and retention. Eur J Nucl Med Mol Imaging (2005) 1.34
Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation. J Vasc Interv Radiol (2012) 1.33
Up-regulation of sonic hedgehog contributes to TGF-β1-induced epithelial to mesenchymal transition in NSCLC cells. PLoS One (2011) 1.30
Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial. Cancer (2012) 1.25
CYP3A4 genetic variant and disease-free survival among white and black men after radical prostatectomy. J Urol (2004) 1.23
Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer. J Thorac Oncol (2011) 1.23
Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma. Urology (2006) 1.19
A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. Am J Transl Res (2010) 1.19
Tumor imaging using 1-(2'-deoxy-2'-18F-fluoro-beta-D-arabinofuranosyl)thymine and PET. J Nucl Med (2007) 1.12
A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer. Invest New Drugs (2005) 1.11
An educational video to increase clinical trials enrollment among breast cancer patients. Breast Cancer Res Treat (2009) 1.11
A pilot trial of spirituality counseling for weight loss maintenance in African American breast cancer survivors. J Natl Med Assoc (2009) 1.09
Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation. Clin Transplant (2010) 1.08
Methods to increase fruit and vegetable intake with and without a decrease in fat intake: compliance and effects on body weight in the nutrition and breast health study. Nutr Cancer (2002) 1.05
Office-based cryoablation of breast fibroadenomas with long-term follow-up. Breast J (2005) 1.03
CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy. Asia Pac J Clin Oncol (2010) 1.00
Office-based ultrasound-guided cryoablation of breast fibroadenomas. Am J Surg (2002) 0.99
Measuring the value of time for methadone maintenance clients: willingness to pay, willingness to accept, and the wage rate. Health Econ (2003) 0.99
Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancer. Am J Clin Oncol (2010) 0.98
Phase I clinical trial of BMS-247550, a derivative of epothilone B, using accelerated titration 2B design. Clin Cancer Res (2005) 0.97
Analysis and reproducibility of 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging in patients with non-small cell lung cancer. Clin Cancer Res (2008) 0.96
Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer. Cancer Chemother Pharmacol (2007) 0.96
Phase II study of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), and celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, in patients with platinum refractory non-small cell lung cancer (NSCLC). J Thorac Oncol (2007) 0.96
Phase II trial of fenretinide in advanced renal carcinoma. Invest New Drugs (2005) 0.95
Retroperitoneal malignant peripheral nerve sheath tumor: evaluation with serial FDG-PET. Clin Nucl Med (2004) 0.95
The effects of time and money prices on treatment attendance for methadone maintenance clients. J Subst Abuse Treat (2004) 0.94
A phase I study of flavopiridol and docetaxel. Invest New Drugs (2006) 0.94
Exfoliated cells in stool: a source for reverse transcription-PCR-based analysis of biomarkers of gastrointestinal cancer. Cancer Epidemiol Biomarkers Prev (2008) 0.93
Phase I study of bryostatin 1 and gemcitabine. Clin Cancer Res (2006) 0.91
Labor market productivity costs for caregivers of children with spina bifida: a population-based analysis. Med Decis Making (2008) 0.91
Optimizing the protocol for pulmonary cryoablation: a comparison of a dual- and triple-freeze protocol. Cardiovasc Intervent Radiol (2010) 0.90
Transcriptional regulation of CXCR4 in prostate cancer: significance of TMPRSS2-ERG fusions. Mol Cancer Res (2013) 0.89
Design of a Mediterranean exchange list diet implemented by telephone counseling. J Am Diet Assoc (2008) 0.89
The natural tumor suppressor protein maspin and potential application in non small cell lung cancer. Curr Pharm Des (2010) 0.88
Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study. Am J Clin Oncol (2003) 0.88
Cytochrome p450 and glutathione transferase expression in human breast cancer. Clin Cancer Res (2003) 0.88
Contemporary impact of transrectal ultrasound lesions for prostate cancer detection. J Urol (2004) 0.88
A phase II study of carboplatin and paclitaxel in adenocarcinoma of unknown primary. Am J Clin Oncol (2005) 0.88
Safety, efficacy, pharmacokinetics, and pharmacodynamics of the combination of sorafenib and tanespimycin. Clin Cancer Res (2010) 0.88
Clinicopathological analysis of primary epithelial appendiceal neoplasms. Med Oncol (2009) 0.87
Effects of low-fat and/or high-fruit-and-vegetable diets on plasma levels of 8-isoprostane-F2alpha in the Nutrition and Breast Health study. Nutr Cancer (2004) 0.87
Cryoablation treatment of benign breast lesions with 12-month follow-up. Am J Surg (2004) 0.87
Effects of high fruit-vegetable and/or low-fat intervention on plasma micronutrient levels. J Am Coll Nutr (2006) 0.87
Soft-tissue cryoablation in diffuse locations: feasibility and intermediate term outcomes. J Vasc Interv Radiol (2013) 0.86
A phase 2 study of TZT-1027, administered weekly to patients with advanced non-small cell lung cancer following treatment with platinum-based chemotherapy. Lung Cancer (2006) 0.86
Influence of lactation history on breast nipple aspirate fluid yields and fluid composition. Breast J (2005) 0.86
Participation and survival of geriatric patients in Phase I clinical trials: the Karmanos Cancer Institute (KCI) experience. J Geriatr Oncol (2011) 0.85
A phase 1 trial of XK469: toxicity profile of a selective topoisomerase IIbeta inhibitor. Invest New Drugs (2006) 0.85
Is cryotherapy the optimal technology for ablation of lung tumors? J Vasc Interv Radiol (2012) 0.85
Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men. Urol Oncol (2006) 0.85
Sinonasal mucosal melanoma: a 13-year experience at a single institution. Skull Base (2009) 0.85
Phase II study of paclitaxel and carboplatin in patients with advanced gastric cancer. Am J Clin Oncol (2003) 0.85
Squamous cell cancer of the anal canal in HIV-infected patients receiving highly active antiretroviral therapy: a single institution experience. Am J Clin Oncol (2011) 0.85
Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort study. Invest New Drugs (2010) 0.85
Induction of specific cellular and humoral responses against renal cell carcinoma after combination therapy with cryoablation and granulocyte-macrophage colony stimulating factor: a pilot study. J Immunother (2011) 0.84
Phase II trial of capecitabine and weekly docetaxel in metastatic renal cell carcinoma. Urology (2008) 0.84
Effects of high fruit-vegetable and/or low-fat intervention on breast nipple aspirate fluid micronutrient levels. Cancer Epidemiol Biomarkers Prev (2007) 0.84
Vitamin D receptor gene polymorphisms and disease free survival after radical prostatectomy. Prostate (2004) 0.83
Women participating in a dietary intervention trial maintain dietary changes without much effect on household members. Nutr Cancer (2006) 0.83
Child health-related quality of life following neurocritical care for traumatic brain injury: an analysis of preference-weighted outcomes. Neurocrit Care (2007) 0.83
Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. ISRN Oncol (2012) 0.83
Mature results of a phase II trial of gemcitabine/paclitaxel given every 2 weeks in patients with advanced non-small-cell lung cancer. Clin Lung Cancer (2007) 0.82
Differential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma. Radiother Oncol (2013) 0.82
Radioprotection of lung tissue by soy isoflavones. J Thorac Oncol (2013) 0.82
A phase II study of rebeccamycin analog (NSC-655649) in metastatic renal cell cancer. Invest New Drugs (2003) 0.82
The impact of CAG repeats in exon 1 of the androgen receptor on disease progression after prostatectomy. Cancer (2005) 0.82
Office-based cryoablation of breast fibroadenomas: 12-month followup. J Am Coll Surg (2004) 0.82
Image-guided percutaneous cryotherapy for the management of gynecologic cancer metastases. Gynecol Oncol (2008) 0.82
Cytochrome p450 and glutathione transferase expression in squamous cell cancer. Clin Cancer Res (2004) 0.81
Protein kinases C isozymes are differentially expressed in human breast carcinomas. Life Sci (2009) 0.81
Impact of race, age, and socioeconomic status on participation in pancreatic cancer clinical trials. Pancreas (2010) 0.80
Safety and efficacy of molecularly targeted agents in patients with metastatic kidney cancer with renal dysfunction. Anticancer Drugs (2011) 0.80
Phase II trial of capecitabine and weekly docetaxel for metastatic castrate resistant prostate cancer. J Urol (2009) 0.80
Breast ultrasound tomography versus MRI for clinical display of anatomy and tumor rendering: preliminary results. AJR Am J Roentgenol (2012) 0.80
Cost-effectiveness and lung cancer clinical trials. Cancer (2003) 0.79